13F reference period
Q3 2026
CUSIP: 698955101
13F reference period
Q3 2026
Institutions Reporting
90
Shares (Excl. Options)
Price
$32.29
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 90 institutions filings for Q3 2026.
Security key
698955101
13F reference period
Q3 2026
13F holders
90
13D/G owners
3
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 698955101:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24% | 28,933,371 | RA Capital Management, L.P. | 11 Jun 2026 | ||||
| FMR LLC | 8.5% | $304,973,738 | 10,292,735 | FMR LLC | 30 Jun 2026 | |||
| ARCH Venture Fund XII, L.P. | 5.3% | $190,010,671 | 6,412,780 | ARCH Venture Fund XII, L.P. | 30 Jun 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24% | 29,177,964 | 9.5% | $942,156,458 | |
| ARCH Venture Management, LLC | 5.3% | 6,412,780 | 13% | $207,068,666 | |
| venBio Partners LLC | 4.4% | 5,266,697 | 34% | $170,061,646 | |
| Alphabet Inc. | 4.1% | 4,919,498 | 0.18% | $158,850,590 | |
| Nextech Invest Ltd. | 3.9% | 4,663,176 | 6.7% | $150,573,953 | |
| Cormorant Asset Management, LP | 3.8% | 4,615,612 | 10% | $149,038,111 | |
| REGENERON PHARMACEUTICALS, INC. | 3.4% | 4,166,666 | 75% | $134,541,645 | |
| Janus Henderson Group Ltd. | 2.7% | 3,275,946 | 0.04% | $105,772,132 | |
| Siren, L.L.C. | 2.5% | 2,992,259 | 2.3% | $96,620,043 | |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2% | 2,368,200 | 0.4% | $76,469,178 | |
| Frazier Life Sciences Management, L.P. | 1.9% | 2,330,750 | 1.9% | $75,259,918 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.6% | 1,880,704 | 0.94% | $60,727,932 | |
| Soleus Capital Management, L.P. | 1.4% | 1,684,512 | 1.9% | $54,392,892 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3% | 1,582,509 | 0% | $51,099,216 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3% | 1,556,246 | 0% | $50,251,183 | |
| GENERAL ATLANTIC, L.P. | 1.3% | 1,538,461 | 2% | $49,676,906 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.83% | 1,004,945 | 0% | $32,457,598 | |
| Foresite Capital Management VI LLC | 0.83% | 999,044 | 5.7% | $32,259,131 | |
| Catalio Capital Management, LP | 0.68% | 824,043 | 4.9% | $26,608,348 | |
| ALLIANCEBERNSTEIN L.P. | 0.63% | 765,186 | 0.01% | $24,707,856 | |
| STATE STREET CORP | 0.63% | 757,790 | 0% | $24,469,039 | |
| Logos Global Management LP | 0.62% | 750,000 | 1.4% | $24,217,500 | |
| Blue Pool Management Ltd. | 0.54% | 650,568 | 63% | $21,006,841 | |
| Casdin Capital, LLC | 0.53% | 645,690 | 0.91% | $20,849,330 | |
| Venrock Adviser, LLC | 0.52% | 625,000 | 0.98% | $20,181,250 |
Quarter history
Holder count, reported shares/value, and median price by quarter.